Skip to main content

Table 1 General characteristics of the participants (n = 942)

From: Dutch women’s intended participation in a risk-based breast cancer screening and prevention programme: a survey study identifying preferences, facilitators and barriers

 

All women

N = 942

Low risk

N = 236

Average risk

N = 228

Moderate risk

N = 239

High risk

N = 239

Age (years), mean (SD)

59.0

(6.3)

58.7

(6.3)

58.6

(6.5)

58.9

(5.9)

59.8

(6.3)

Education level, n (%)

 Lower education

249

(26.4)

65

(27.6)

58

(25.4)

63

(26.4)

63

(26.4)

 Higher secondary education

372

(39.5)

82

(34.7)

97

(42.5)

96

(40.2)

97

(40.6)

 Higher vocational qualification

321

(34.1)

89

(37.7)

73

(32.1)

80

(33.4)

79

(33.0)

Marital status, n living with partner (%)

729

(77.3)

187

(79.2)

180

(78.9)

188

(78.7)

174

(72.8)

First-degree family history breast cancer, n yes (%)

204

(21.7)

47

(19.9)

52

(22.8)

47

(19.7)

58

(24.3)

Body mass index (kg/m2), mean (SD)a

26.3

(4.8)

26.5

(4.9)

26.1

(4.6)

26.6

(5.5)

26.0

(4.1)

Medical condition, n ≥ 2 diagnosed (%)b

424

(45.0)

119

(50.4)

96

(42.1)

103

(43.1)

106

(44.4)

Current medication use, n yes (%)

391

(41.5)

109

(46.2)

85

(37.3)

91

(38.1)

106

(44.4)

Current MHTc use, n yes (%)

33

(3.5)

9

(3.8)

5

(2.2)

12

(5.0)

7

(3.0)

Benign breast disease, n yes (%)

272

(28.9)

79

(33.5)

64

(28.1)

68

(28.5)

61

(25.5)

Perceived breast cancer risk (%)

 Low

182

(19.3)

48

(20.3)

44

(19.3)

47

(19.7)

43

(18.0)

 Below average

186

(19.7)

45

(19.1)

49

(21.5)

40

(16.7)

52

(21.8)

 Average

498

(52.9)

126

(53.4)

121

(53.1)

130

(54.4)

121

(50.6)

 Moderate

54

(5.7)

10

(4.2)

10

(4.4)

16

(6.7)

18

(7.5)

 High

5

(0.5)

2

(0.8)

1

(0.4)

1

(0.4)

1

(0.4)

 Missing value

17

(1.8)

5

(2.1)

3

(1.3)

5

(2.1)

4

(1.7)

General health score, mean (SD)

82.1

(14.2)

81.3

(14.4)

81.7

(15.5)

83.8

(12.8)

81.5

(13.9)

Life events, n ≥ 2 (%)d

264

(28.0)

74

(31.4)

64

(28.1)

63

(26.4)

63

(26.4)

HLOCe, n (%)

 Internal

300

(31.8)

78

(33.1)

69

(30.3)

73

(30.5)

80

(33.5)

 Physician

67

(7.1)

11

(4.7)

11

(4.8)

27

(11.3)

18

(7.5)

 Chance

447

(47.5)

115

(48.7)

111

(48.7)

107

(44.8)

114

(47.7)

 No clear preference

113

(12.0)

29

(12.3)

34

(14.9)

27

(11.3)

23

(9.6)

 Missing value

15

(1.6)

3

(1.3)

3

(1.3)

5

(2.1)

4

(1.7)

Belief in medicines, mean (SD)

 Harm

9.0

(2.5)

9.0

(2.5)

9.2

(26.7)

9.0

(2.5)

9.0

(2.5)

 Overuse

11.5

(3.3)

11.6

(3.3)

11.6

(3.4)

11.6

(3.3)

11.3

(3.3)

Health anxiety, mean (SD)

7.7

(4.0)

7.6

(4.1)

7.7

(3.8)

7.6

(3.8)

7.8

(4.2)

  1. a7 women with missing value (0.7%); b ≥ 2 medical diagnosis to indicate co-morbidity; c MHT = menopausal hormone therapy; d ≥ 2 life events to enable meaningful group comparisons; e HLOC = health locus of control